Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Most of the data came from five states that list these indications as qualifying conditions for the use of medical cannabis. How to Use the Data.

Data 105

Data Clinical Trials Research and Development Indica 105

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

MARCH 16, 2022

The PsyBio team has extensive experience in drug discovery and development based on synthetic biology, metabolic engineering, medicinal chemistry and clinical pharmacology, as well as clinical and regulatory expertise progressing drugs through human studies and governmental protocols. About PsyBio Therapeutics Corp.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

Cannabis Law Report

AUGUST 17, 2021

Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. Key Topics Covered: 1.0 Therapeutic Medical Devices are Preferred by Physicians and Patients for Acute and Chronic Respiratory Conditions. They can offer their drugs with an innovative inhaler device. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Children who suffer from these conditions generally experience social and developmental delays due to constant seizures. What Does Epidiolex Treat?

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. Additional CB4 products from the Opticann suite of branded products will be launched in the upcoming weeks, including CB4 Derma skin cream and CB4 Clear face gel skincare products uniquely backed by product specific clinical trial data.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

The Cannigma

JUNE 24, 2021

While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. By interacting with the receptors of the ECS, cannabis modulates the bodily functions that cause or exacerbate health conditions.

CBD 75

CBD Microdosing Edibles Sleep 75

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. for the production of cannabis used in federally-regulated clinical trials. It simply is a safer substitute.”.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

FEBRUARY 3, 2022

The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. Clinical Trials of Cannabis Are Still on Going.

Indica 52

Indica Oil Legalization Research and Development 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Key Topics Covered: Chapter 1 Methodology and Scope. North America Legal Cannabis Number of clinical trials.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

The Cannigma

JUNE 15, 2021

More and more CBD products on the market promise relief from pain, depression, anxiety, neurodegenerative conditions, and a plethora of other symptoms and conditions. Benzodiazepines are often prescribed for conditions such as anxiety, insomnia, seizure control, and muscle relaxation. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 11, 2019

Food and Drug Administration (FDA) retains its authority to regulate ingestible and topical products, including those that contain hemp and hemp extracts such as CBD. This is unprecedented; the FDA has never used this authority for any ingredient determined to only be permissible in pharmaceutical drugs per the IND Preclusion.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

Medical Cannabis Seedbank

FEBRUARY 26, 2018

Cannabis and cancer, quite a popular topic, however, many people have to face the reality of either; dealing with cancer themselves or having an immediate family member or friend having to fight the deadly disease. This can become reality with continued research and funding of clinical trials. Encourage appetite.

Treatment 63

Treatment Patients Clinical Trials THC 63

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? I’ve seen it as flower, I’ve seen it as topical, which has anti-bacterial and anti-psoriatic effects. Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

FloridaMarijuana.net

AUGUST 13, 2018

Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. Pharmaceuticals come with side effects, though, and may vary from person-to-person. Medications can be used along with therapy.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders.

CBD 144

CBD Seed-To-Sale Food Access 144

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. TO Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

FloridaMarijuana.net

OCTOBER 19, 2018

Depression can be situational, but Clinical Depression, which comes and goes and/or lasts for more than a few days, is a chemical imbalance within the central nervous system. Depression can make these conditions worse and vice versa. Some patients find success with pharmaceuticals and talk-therapy.

Marijuana 189

Marijuana Research and Development Patients Clinical Trials 189

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. Lenabasum: Corbus Pharmaceuticals. Cannabis oil: TO Pharmaceuticals. INM-755: InMed Pharmaceuticals. Corbus Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Key Topics Covered: Chapter 1 Methodology and Scope. GW Pharmaceuticals, PLC. Market Segmentation.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

SEPTEMBER 10, 2019

” Here’s some of the topics covered in their latest newsletter. Forbes reported on Hopkins researchers’ recommendation that, if psilocybin should clear Phase III clinical trials, the FDA should reclassify it from a Schedule I to a Schedule IV drug. Psychedelic Research News.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Cannabis Law Report

MARCH 29, 2020

When companies, individuals or groups conduct or commission research of any kind on cannabis product one or more of its various forms (edibles, topicals, beverages, etc.) o Medical conditions: A panel of doctors must be present at the time of any product research to ensure no adverse effects lessen or damage the health of participants.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Alchimia

OCTOBER 15, 2021

After sifting through heaps of scientific reports, here are some of CBD’s most interesting or unexpected health benefits : Ten fascinating benefits from CBD to treat unexpected conditions. You might think antibiotic creams are the only way to treat acne, but scientists claim CBD is a promising therapeutic agent for this dermatological issue.

CBD 59

CBD Sleep Treatment Cannabinoids 59

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Puff Puff Post

SEPTEMBER 16, 2019

Clinical toolkits to help navigate patient assessment and follow-ups. “A significant issue preventing the consideration of cannabinoid medicine by healthcare professionals is that the topic is not typically included in the medical school curriculum,” comments Dr. Mark Ware, Chief Medical Officer, Canopy Growth.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

SEPTEMBER 16, 2019

Clinical toolkits to help navigate patient assessment and follow-ups. “A significant issue preventing the consideration of cannabinoid medicine by healthcare professionals is that the topic is not typically included in the medical school curriculum,” comments Dr. Mark Ware, Chief Medical Officer, Canopy Growth.

Programs 40

Programs Research and Development Education Treatment 40

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. I don’t know if we’ll have topicals initially, or later on. We have autism and epilepsy.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79